Aging promotes neoplastic disease through effects on the tissue microenvironment by Marongiu, Fabio et al.




Aging is the strongest risk factor for neoplastic disease. 
However, the mechanistic links between these two 
complex biological processes are far from being fully 
elucidated. A time-dependent, progressive accumulation 
of critical mutagenic events in rare cells and/or failure 
to clear putative pre-neoplastic cells due to a decline in 
immune-surveillance are among the most considered 
hypothesis to relate aging and cancer [1-2]. On the other 
hand, there is now general consensus on the notion that 
the emergence of pre-neoplastic and neoplastic cell 
populations is heavily dependent on biological cues 
emanating from the host tissue microenvironment in 
which cancer arises [3,7]. Along these lines, we have 
observed that the imposition of a long-lasting constraint 
on the regenerative capacity of the liver is conducive to 
the rapid growth and progression of transplanted pre-
neoplastic  hepatocytes,  while  the  same  cells   remain  
 
quiescent when injected into a normal, untreated host 
liver [8]. These results suggested that loss of 
regenerative potential in tissues where this property is 
functionally relevant may generate a biological driving 
force fostering the selective outgrowth of putative 
altered cells [4,9]. Since a reduced regenerative 
potential in several organs, including liver, is also a 
hallmark of aging [10,11], it is reasonable to 
hypothesize that alterations induced by the aging 
process might be similarly associated to the emergence 
of a neoplastic-prone tissue landscape, which would 
contribute to the increased frequency of cancer observed 
with advancing age [9]. Based on these premises, the 
present studies were undertaken to investigate the fate 
of pre-neoplastic hepatocytes isolated from rat liver 
nodules and orthotopically transplanted into syngeneic 
recipients of different age. The results indicate that the 
microenvironment of the aged host supports the growth 
and progression of pre-neoplastic hepatocytes; by 


















the prevention and  treatment of neoplasia.  In  these  studies,  the hypothesis was  tested  that aging may  fuel
carcinogenesis  via  alterations  imposed  in  the  tissue microenvironment.  Preneoplastic  hepatocytes  isolated
from  liver  nodules were  orthotopically  injected  into  either  young  or  old  syngeneic  rats  and  their  fate was
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contrast, no such expansion of transplanted cells was 




Size of nodular cell clusters in young and old 
recipients 
 
In a first study, we examined the size distribution of cell 
clusters originating from nodular hepatocytes trans-
planted in either young or old recipient livers and 













































the average number of cells per cluster in each animal. 
In rats transplanted at 4 months of age, the highest mean 
size of clusters per animal was 21±3, while the largest 
single cluster comprised 27 cells. By contrast, the same 
figures were much higher in the group transplanted at 
18 months of age, being 81±29 and 563 cells, 
respectively. This finding was confirmed when the 
mean size of clusters was compared in the two groups 
(6 animals each, panel B in Figure 1): 11±3 cells per 
cluster were detected in young recipients, while this 















































killed  3 months  after  Tx  (see  Experimental  procedures  for  details).  Panel  (A) mean  cluster  size  (±  SE)  in  individual
animals. Panel (B) mean cluster size per group. Data are mean ± SE; **significantly different from young group:P<0.01. 
Table  1.  Incidence  of  hepatic  lesions  in  animal  transplanted  with  primary  pre‐
neoplastic hepatocytes at young or old age. 












3-5 0/21 none — none — 
18-20 17/18 56 1-8 mm 7 1-3 cm 
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The growth of hepatocyte nodules in young and old 
recipients 
 
In a second series of experiments, young (3-5 months 
old) and aged (18-20 months old) Fischer rats were 
similarly transplanted with nodular hepatocytes and 
killed 8 months later. On macroscopic examination 
(Table 1), no visible lesion were seen in any of 21 
recipient animals transplanted at young age (Figure 2, 
panel A). In stark contrast, 17/18 animals transplanted 
at old age displayed visible hepatic nodules, ranging 












































measuring up to 3 cm in diameter (Figure 2, panel B). 
All large lesions expressed the DPPIV marker enzyme, 
indicating that they originated from the transplanted cell 
population (Figure 3, panels A-C). Their gross 
appearance and structural morphology was similar to that 
of primary hepatocyte nodules generated through 
classical protocols for the induction of carcinogenesis in 
rat liver [16]. They were generally paler in color 
compared to surrounding tissue, displayed a prominent 
vasculature and were composed of two-three cell-thick 















































old age and killed 8 months after Tx. Panel  (A)  liver  from a rat  transplanted at 5 months of age and killed 8 months
later:  liver  surface  is  regularly  smooth  and  no  lesions were  detected.  Panel  (B)  liver  from  a  rat  transplanted  at  20
months of age and killed 8 months later: note the presence of two large nodules with prominent vasculature (arrows). 
Figure 3. Panels (A) and (B) Histochemical staining for DPPIV of liver samples obtained from rats transplanted with pre‐
neoplastic  hepatocytes  at  young  age  and  killed  8 months  after  Tx.  Small  clusters  of  DPPIV‐expressing  hepatocytes
(orange‐rust) were discerned in all animals. Histochemical staining for DPPIV (panel C) and standard H&E staining (panel
D) of a  large hepatic nodule  from a  rat  transplanted with pre‐neoplastic hepatocytes at old age and killed 8 months
later. Note the typical appearance of nodular hepatocytes arranged in multiple cell‐thick plates. Magnification: 100x.  
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Markers of cell senescence in aged rat liver 
 
In order to identify alterations in the tissue 
microenvironment possibly relevant to the growth of 
transplanted cells in the aged liver, expression of markers 
of cell senescence was investigated. Cell senescence has 
long been interpreted as a fail-safe mechanism to limit 
neoplastic progression of altered cells [12]. On the other 
hand, it is now well established that it can also contribute 
to the emergence of the neoplastic phenotype, possibly 
through secretion of a host of factors, variably referred to 
as senescence-associated secretory phenotype (SASP) 
[13] or senescence-messaging secretome (SMS) [14], and 
comprising cytokines, growth factors and proteases. In 
light of the results reported above, expression of SA-β-
gal, one of the most consistent markers of cell 
senescence, was determined in the liver of young vs. 
aged rats. Typical results are shown in Figure 4. Diffuse 
histochemical staining for SA-β-gal was observed in liver 
sections obtained from 18-month old animals, while it 
was a rare finding in the corresponding samples from 
young controls.  
 
On the other hand, no significant changes were seen 
between young and aged animals in the hepatic 
expression of other markers that have been associated 
with cell senescence, such as the cell cycle inhibitors p21 
and p27; however, aged livers displayed higher levels of 



























We next measured the levels of expression of IL6, a 
pro-inflammatory cytokine and a main component of 
SASP which has also been implicated in liver 
regeneration and repair [16]. Interestingly, both mRNA 
and IL6 protein were found to be increased in the liver 
of aged rats compared to young controls (Figure 5). In 
light of these results, we further investigated expression 
of the downstream effector of IL6, signal transducer and 
activator of transcription 3 (STAT3) in the liver of aged 
animals transplanted with nodular hepatocytes. 
However, only rare cells, scattered throughout the liver, 
showed nuclear staining for STAT3, with no specificity 




A better understanding of the bases of the intimate 
association between aging and cancer is likely to widen 
our opportunities to devise more effective approaches 
for the prevention and treatment of neoplastic disease. 
In order to unravel the intricacies of such complex 
relationship, biological coordinates need to be first 
firmly established. The results of these studies provide a 
contribution to this end, indicating that alterations in the 
tissue microenvironment of the aged rat liver can foster 
the growth of transplanted pre-neoplastic hepatocytes. 
They can therefore account, at least in part, for the 

































































Primary pre-neoplastic hepatocytes were isolated from 
hepatic nodules generated according to a classical 
experimental model of chemical carcinogenesis [13,17]. 
They were then transferred into either young or old 
syngeneic hosts and their fate was followed over time 
for up to 8 months post-infusion, using the established 
DPPIV enzyme system as a tag [8,12]. 
 
The first finding to be highlighted is the very limited 
growth of transplanted cells seen in the liver of young 
recipients at either 3 or 8 months after Tx. Incidentally, 
we have now extended this observation to 12 months 
post-Tx, with similar results (data not presented). This 
indicates that the transplanted pre-neoplastic cell 
population is not endowed with any inherent degree of 
growth autonomy. Rather, its selective focal expansion 
appears to be heavily dependent on cues emanating 
from the tissue microenvironment, consistent with our 
earlier observations [8].  
 
By contrast, the same cell population was able to grow 
and generate focal proliferative lesions, including large 
hepatocyte nodules, upon transplantation into the liver 
of aged animals, indicating that the microenvironment 
































pre-neoplastic cells isolated from a syngenic donor. In 
more general terms, these results support the conclusion 
that aging is associated with the emergence of a 
neoplastic-prone tissue landscape, which is likely to 
represent a key biological driving force to explain the 
increased incidence of cancer with advancing age. To 
our knowledge, this is the first study reporting on the 
fate of a primary pre-neoplastic cell population 
orthotopically transplanted in normal, untreated 
recipient animals of different age. 
 
Our findings are reminiscent of those of McCullough et 
al. [17,18], who reported on the age-dependent 
regulation of the tumorigenic potential of neoplastically 
transformed rat liver epithelial cells by the liver 
microenvironment. However, those studies and ours 
differ in important experimental details, which impact 
on the interpretation and significance of results. Firstly, 
a rat liver epithelial cell line, grown in vitro, was 
employed by McCullough et al., while freshly isolated 
primary hepatocytes were used in the present 
investigation, with no in vitro passage. Secondly, the 
cell line in McCullough’s studies was already 
neoplastic, with a full tumorigenic potential and a 




staining  for  DPPIV+  (panel  C)  and  immuno‐histochemical  staining  for  STAT3  (panel  D)  in  clusters  of  transplanted
nodular hepatocytes. Only rare STAT3+ nuclei were detected in the aged rat liver (panel E). 100x magnification.  
www.aging‐us.com  3395  AGING (Albany NY) 
and interpret. By contrast, cells isolated from hepatic 
nodules were pre-neoplastic, with no signs of growth 
autonomy. Furthermore, their biology has been 
extensively characterized: if left in the original host, 
they will progress to overt hepatocellular carcinoma in 
approximately 6 months from the time of isolation [19]. 
Overall, a continuity of the in vivo neoplastic process 
was maintained in the present experimental setup 
between the original host (the donor) and the recipient. 
Thus, our findings bear direct relevance to the 
pathogenesis of neoplastic disease as it occurs in vivo in 
experimental animals and in humans. 
 
Important insights can be drawn from these results 
regarding the biological mechanisms mediating the 
effects of aging on carcinogenesis. A most entertained 
hypothesis places emphasis on the time-driven 
progressive accumulation of mutagenic events in rare 
cells that ultimately would lead to the acquisition of a 
neoplastic phenotype [1,20]. While our results are not at 
odds with this postulation, they do rule out the 
possibility that such mechanism is acting alone and/or it 
is of major biological relevance. In fact, the presence of 
altered, pre-neoplastic hepatocytes in the liver of young 
recipients does not result in any significant growth of 
focal lesions for several months post-transplantation, 
suggesting that it not sufficient, per se, to fuel 
carcinogenesis.  
 
Another possibility that is often invoked to relate aging 
and cancer pertains to a gradual waning of the immune 
surveillance mechanisms in old age, such that 
altered/pre-neoplastic/neoplastic cells are no longer 
targeted for clearance and can therefore expand 
unchecked in the host [2,21,22]. Our present results 
would appear compatible with such scenario. However, 
we consider it unlikely for the following reasons. 
Firstly, donor and recipient animals are syngeneic and 
transplanted pre-neoplastic cells are still present in 
young host livers several months after transplantation, 
indicating that they are not cleared by the immune 
system. Secondly, we have obtained similar findings 
with normal hepatocyte transplantation [23], indicating 
that the microenvironment of the aged rat liver is more 
permissive for the growth of both pre-neoplastic and 
normal homotypic cells, which are not expected to be a 
target for clearance by the immune system in a 
syngeneic setting.  
 
Over the last several years, cell senescence has taken 
centre stage for its possible involvement as a pro-
carcinogenic stimulus. This concept has been 
specifically linked to the peculiar secretory phenotype 
of senescent cells, SASP, which includes cytokines, 
proteases and growth factors, among others, and can 
profoundly impact the biological response of the 
surrounding tissue [13,14,24-27]. Indeed, we found that 
incidence of cell senescence, as monitored by the 
expression of SA-β-gal, is increased in aged rat liver. 
Furthermore, levels of IL6, a pro-inflammatory cytokine 
and a major component of SASP which is also involved 
in liver regeneration and repair [16], were also higher in 
the liver of older animals. It is therefore reasonable to 
hypothesize that the presence of cell senescence and the 
accompanying SASP may mediate, at least in part, the 
observed promoting effect of the aged liver 
microenvironment on the growth of transplanted pre-
neoplastic hepatocytes. Consistent with this 
postulation, we have previously shown that clearance 
of senescent cells delays carcinogenesis in a rat liver 
model [24].  
 
However, other complementary mechanisms, such as 
cell competition [28-30], cannot be ruled out. The 
declining fitness of liver parenchyma with age, 
including a cell-autonomous decrease in proliferative 
potential [31], may well contribute to the selective 
emergence of altered cells[32], as it has been proposed 
in bone marrow during leukemogenesis [33,34,35]. 
Interestingly, it was recently reported that chronic 
inflammation associated with old age contributes to a 
reduced fitness of B cell progenitor populations, 
favoring the selection for cells harboring oncogenic 
mutations [36]. 
 
Irrespective of the specific mechanisms, our findings 
highlight an important role an age-associated altered 
tissue microenvironment in selecting for the emergence 
of pre-neoplastic cell populations. The finding of a 
direct pathogenetic link between aging and 
carcinogenesis reinforces the notion that similar 
strategies may help delaying both processes [37]. 
 




All animals were maintained on daily cycles of 
alternating 12 h light/darkness with food and water 
available ad libitum. They were fed Purina Rodent Lab 
Chow diet (Ditta Mucedola, Italy) throughout the 
experiments and received humane care according to the 
criteria outlined in the National Institutes of Health 
Publication 86-23, revised 1985. Animal studies were 
reviewed and approved by the Institutional Animal Care 
and Use Committee of the University of Cagliari. In 
order to distinguish donor-derived from recipient cells 
in the liver, the dipeptidyl-peptidase type IV-deficient 
(DPPIV-) rat model was used [38]. A colony of DPPIV- 
F344 rats has been established in our laboratory, at the 
Department of Biomedical Sciences, University of 
Cagliari. DPPIV- animals were used as recipients, while 
www.aging‐us.com  3396  AGING (Albany NY) 
donor rats were syngeneic F344, DPPIV+ and were 
purchased from Charles River, Milan, Italy.  
 
Induction of liver nodules in donor rats and isolation 
of hepatocytes 
 
Hepatocyte nodules were induced according to a well-
characterized experimental model in the rat [19], as 
previously described [8]. Briefly, two-month old male 
Fischer 344 rats, expressing DPPIV enzyme activity, 
were injected with a single dose of diethylnitrosamine 
(DENA, 200 mg/kg. b.w., i.p., Sigma-Aldrich Chemical 
Co., St. Louis, MO) followed, 3 weeks later, by 
exposure to a modified version of the Solt and Farber 
protocol [39], to stimulate the growth of hepatocyte foci 
and nodules. Such protocol consisted of three 
consecutive daily doses of 2-acetylaminofluorene (20 
mg/kg b.w., given by gavage tube, from Sigma-Aldrich) 
followed, on the fourth day, by a single administration 
of CCl4 (0.2 ml/kg b.w., by gavage, mixed in corn oil, 
1:1 v:v). Six months after the initial treatment livers 
were perfused according to a standard 2-step 
collagenase perfusion technique [40,41]. Typically, 3 to 
5 large (5-10mm in size) persistent nodules are present 
in the liver at this time point using the above 
experimental protocol. When left in situ, a subgroup of 
these nodules (an average of 1 or 2 per animal), will 
progress to cancer within about 1 year [19]. Large (>5 
mm) nodules were physically separated from 
surrounding tissue and isolated cells were suspended in 
PBS and prepared for transplantation experiments. Prior 
to transplantation, cell suspension was filtered through a 
nylon mesh with a pore diameter of 100μ, in order to 
eliminate any large cell clumps. Cell viability, 
determined by trypan blue dye exclusion, was ~85% in 




Young (3-5 months old) or aged (18-20 months old) 
Fisher 344 rats of the DPPIV- strain were used as 
recipients. They were injected with 5x105 cells freshly 
isolated from DPPIV+ hepatocyte nodules, via a 
mesenteric vein [8]. Animals from various groups were 
sacrificed at different time points during the experiment, 
as indicated in the Results section. Liver samples were 
fixed in 10% buffered formaldehyde or snap frozen. 
Histochemical determination of DPPIV enzyme activity 
was performed as described [8]. At least ten random 
sections were cut from each liver lobe of each animal 
and stained for DPPIV enzyme activity. Sections were 
then analyzed under the microscope and the number of 
hepatocytes for each DPPIV+ cluster was evaluated. 
Data from two separate experiments are reported. Data 
represent means±S.E. Statistical analysis was performed 
using the Student t test. 
Staining for senescence associated β-galactosidase 
activity 
 
Detection of senescence associated β-galactosidase 
(SA-β-Gal) activity was performed as described [42]. 
Immediately before staining, X-Gal stock solution was 
prepared by dissolving 20mg/ml X-Gal (Invitrogen, 
Carlsbed, CA) in dimetylformamide. SA-β-Gal staining 
solution was prepared as follows: 1 mg/ml of X-Gal 
stock solution were dissolved in 40 mM citric acid in 
sodium phosphate, pH 6.0/5 mM potassium 
ferrocyanide/5 mM potassium ferricyanide/150 mM 
NaCl/2 mM MgCl2. Frozen sections of 10-µm 
thickness were fixed for 5’ in 4% formaldehyde/0.5% 
glutaraldehyde at 4°C, washed in PBS and incubated in 
fresh SA-β-Gal staining solution for 16h at 37°C. No 
special blocking step is required to perform the staining. 
Sections were counterstained with Hematoxylin. 
 
Histochemistry and immunohistochemistry  
 
To follow the fate of transplanted cells, histochemical 
detection of DPP-IV positive clusters was performed on 
5µm frozen sections as previously described [38].  
Immunohistochemical staining for p-STAT 3 was 
performed on serial frozen sections. Slides were fixed 
with 3% formalin, blocked for 30’ and incubated with 
the primary antibody (Cell Signalling Technology, 
Danvers, MA) overnight at 4°C. Detection of specific 
signal was accomplished using an HRP/AEC detection 




Liver tissue samples were homogenized in RIPA lysis 
buffer containing Protease Inhibitors, then centrifuged 
at 12000 rpm for 30’ at 4°C. Protein concentration in 
supernatants was measured using the BCA method [42]. 
Samples (20µg protein) were prepared in Laemmli 
buffer, boiled at 95°C for 5’ then loaded into SDS-
PAGE precast gels (Biorad, Hercules, CA) and run 
under denaturing conditions. Proteins were transferred 
onto nitrocellulose membranes (Amersham, UK), 
blocked with 5% non-fat milk for 1 h, then incubated 
with primary antibody for p21, p27 and p53 (Santa 
Cruz, Santa Cruz, CA), IL6, beta actin and gapdh 
(Abcam) overnight at 4°C. Membranes were washed  
and incubated for 2 h with the appropriate secondary 
antibody conjugated with HRP. Protein bands were 
detected using a chemoluminescent substrate (Biorad) 
and imaged onto Kodak film.  
 
RNA isolation, RT-PCR and Real-Time qPCR 
 
Total RNA was isolated using TRIzol reagent 
(Invitrogen, Carlsbad, CA) according to the 
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manufacturer’s protocol. RNA integrity and purity were 
confirmed by 1% agarose gel electrophoresis and 
OD260/OD280 nm absorption ratio >1.8. Two grams of 
DNase-I treated RNA of each sample were reverse-
transcribed by PCR using Promega reagents. The 
resulting cDNA was analyzed by quantitative real-time 
PCR using specific TaqMan assays and TaqMan Gene 
Expression Master Mix on an StepOne System (all from 
Applied Biosystems, Carlbad, CA). The rat specific 
assays were: IL-6 (Rn01410330_m1); β2-microglobulin 
(Rn00560865_m1). For both assays the thermal profile 
was as follows: 50˚C for 2 minutes, 95˚C for 10 
minutes, 45 cycles at 95˚C for 15 seconds and 60˚C for 
1 minute. Fold change was calculated by the 2-ΔΔCT 
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